Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

10.73
Delayed Data
As of Jul 31
 +0.14 / +1.32%
Today’s Change
10.26
Today|||52-Week Range
18.94
-37.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues71.4K71.4K0.000.00
 
 
 
Depreciation And Amortization38.3K38.3K38.3K38.3K
 
 
 
 
 
 
Operating ExpensesGross Income-----38.3K-38.3K
 
 
 
General Expenses6.1M6.9M7.0M7.8M
 
 
 
 
 
Research And Development4.1M5.0M5.1M6.0M
 
 
 
 
 
Total Operating Expenses6.1M7.0M7.1M7.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.0M-6.9M-7.1M-7.8M
 
 
 
 
 
Other Expenses-10.5K-8.5K121.6K122.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.0M-6.9M-6.9M-7.7M
 
 
 
 
 
Net Income-6.0M-6.9M-6.9M-7.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.9M13.0M13.0M16.6M
 
 
 
 
 
Shares To Calculate EPS Diluted12.9M13.0M13.0M16.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.53-$0.53-$0.46
 
 
 
 
 
EPS Diluted-$0.47-$0.53-$0.53-$0.46